3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mutational signatures and the genomic landscape of betel quid chewing‐associated tongue carcinoma

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Our study presents the genetic landscape betel quid chewing‐associated tongue carcinomas (BQ‐TCs). We compared the genetic landscape and mutational signatures of 15 BQ‐TCs, five nonbetel quid chewing‐associated tongue carcinomas (nBQ‐TCs), and 82 tongue carcinomas in general population from the TCGA (TCGA‐TCs) project. The highlights of this research mainly include: (a) The genetic landscape of BQ‐TC was characterized with frequent mutations in RASA1 gene and in CpG islands throughout the genome. (b) The BQ‐TC had a distinct mutational signature from that of nBQ‐TC and tongue carcinomas in the general population, and this signature was associated with the mutations in RASA1 and in CpG islands. (c) Our study indicates that betel quid (BQ) chewing classifies a distinct group of tongue carcinoma. The BQ chewing might not contribute to the tumorigenesis of tongue carcinomas as a mutagen.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Nucleotide excision repair is impaired by binding of transcription factors to DNA.

          Somatic mutations are the driving force of cancer genome evolution. The rate of somatic mutations appears to be greatly variable across the genome due to variations in chromatin organization, DNA accessibility and replication timing. However, other variables that may influence the mutation rate locally are unknown, such as a role for DNA-binding proteins, for example. Here we demonstrate that the rate of somatic mutations in melanomas is highly increased at active transcription factor binding sites and nucleosome embedded DNA, compared to their flanking regions. Using recently available excision-repair sequencing (XR-seq) data, we show that the higher mutation rate at these sites is caused by a decrease of the levels of nucleotide excision repair (NER) activity. Our work demonstrates that DNA-bound proteins interfere with the NER machinery, which results in an increased rate of DNA mutations at the protein binding sites. This finding has important implications for our understanding of mutational and DNA repair processes and in the identification of cancer driver mutations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

            We performed exome sequencing to detect somatic mutations in protein-coding regions in seven melanoma cell lines and donor-matched germline cells. All melanoma samples had high numbers of somatic mutations, which showed the hallmark of UV-induced DNA repair. Such a hallmark was absent in tumor sample-specific mutations in two metastases derived from the same individual. Two melanomas with non-canonical BRAF mutations harbored gain-of-function MAP2K1 and MAP2K2 (MEK1 and MEK2, respectively) mutations, resulting in constitutive ERK phosphorylation and higher resistance to MEK inhibitors. Screening a larger cohort of individuals with melanoma revealed the presence of recurring somatic MAP2K1 and MAP2K2 mutations, which occurred at an overall frequency of 8%. Furthermore, missense and nonsense somatic mutations were frequently found in three candidate melanoma genes, FAT4, LRP1B and DSC1.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global epidemiology of areca nut usage.

              A substantial proportion of the world's population is engaged in chewing areca nut and the habit is endemic throughout the Indian subcontinent, large parts of south Asia and Melanesia. A large variety of ingredients, including tobacco, may be used along with areca nut constituting a betel quid. The composition and method of chewing can vary widely from country to country and these population variations are described in this review. Some populations are known to use areca nut without tobacco providing good opportunities to further research the carcinogenecity of areca nut. Some interesting trends on chewing patterns have emerged from recent data, suggesting a decline in the habit in some countries such as Thailand while the prevalence of areca nut use is rising in India and Taiwan.
                Bookmark

                Author and article information

                Contributors
                nisong168@sina.com
                dryujianjun@sina.com
                zengyx@sysucc.org.cn
                Journal
                Cancer Med
                Cancer Med
                10.1002/(ISSN)2045-7634
                CAM4
                Cancer Medicine
                John Wiley and Sons Inc. (Hoboken )
                2045-7634
                22 January 2019
                February 2019
                : 8
                : 2 ( doiID: 10.1002/cam4.2019.8.issue-2 )
                : 701-711
                Affiliations
                [ 1 ] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
                [ 2 ] State Key Lab of Molecular Oncology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
                [ 3 ] Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University Changsha Hunan China
                [ 4 ] Department of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
                [ 5 ] Laboratory of Cell and Molecular Biology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
                [ 6 ] Department of Head and Neck Surgery, National Cancer Center/Cancer Institute and Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China
                [ 7 ] Department of Head and Neck Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha Hunan China
                [ 8 ] Department of Experimental Research, Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong Province China
                Author notes
                [*] [* ] Correspondence

                Song Ni, Department of Head and Neck Surgery, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China.

                Emails: nisong168@ 123456sina.com

                Jianjun Yu, Department of Head and Neck Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

                Email: dryujianjun@ 123456sina.com

                and

                Yi‐xin Zeng, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.

                Email: zengyx@ 123456sysucc.org.cn

                Author information
                http://orcid.org/0000-0001-8811-3568
                Article
                CAM41888
                10.1002/cam4.1888
                6382727
                30672146
                6add4fd4-1f06-4f39-ba3a-e8bb7089e07b
                © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 April 2018
                : 29 October 2018
                : 30 October 2018
                Page count
                Figures: 6, Tables: 0, Pages: 11, Words: 13691
                Funding
                Funded by: National Key Basic Research Program of China
                Award ID: 2015CB553900
                Award ID: /2015CB553902
                Funded by: National Natural Science Foundation Fund
                Award ID: 81472559
                Funded by: PUMC Fundamental Research Funds
                Award ID: JK2013A21
                Award ID: JK2014B10
                Funded by: CAMS Innovation Fund for Medical Sciences (CIFMS)
                Award ID: 2016-I2M-1-001
                Award ID: 2016ZX310181
                Categories
                Original Research
                Cancer Biology
                Original Research
                Custom metadata
                2.0
                cam41888
                February 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.5.9 mode:remove_FC converted:20.02.2019

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article